Covan Meropenem 500 mg IV, 1 000 mg IV Powder for solution for intravenous injection
PDF Leaflet Revision Date: 18 June 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of infections caused by bacteria sensitive to meropenem.
Dosage (summary)
Adults: 500 mg to 1 g IV every 8 hours; adjust for renal impairment.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
- Paediatrics
Pregnancy & Breastfeeding
Safety in pregnancy not established; not recommended during breastfeeding.
Key Drug Interactions
- Probenecid
- Valproic acid
- Warfarin
Contraindications
- Hypersensitivity to meropenem
- History of hypersensitivity to beta-lactams
Common side effects
- Diarrhoea
- Nausea
- Injection site inflammation
Counselling Points
- Report any allergic reactions
- Monitor for gastrointestinal symptoms
- Avoid use with valproic acid
Serious warnings
- Serious hypersensitivity reactions
- Seizures
- Hepatic function monitoring required
Important Disclaimer
The Covan Meropenem 500 mg IV, 1 000 mg IV Powder for solution for intravenous injection professional information leaflet below is the property of Adcock Ingram Critical Care and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
